At the crossroads of venous insufficiency and hemorrhoidal disease: Daflon 500 mg--repercussions of venous insufficiency on everyday life.
A research program has been developed to define an evaluation tool capable of assessing the impact of venous insufficiency and its treatments on the patient's everyday life. The methodology is described in the first part of this paper, followed by the results of the first phase of the research program, based on two surveys: a "qualitative" survey in a population of severely affected patients and a "quantitative" survey in a population of 150 patients.
Launois
R
R
Arcos (Analyses et Rechesches en Economie de la Santé), Issy Les Moulineaux, France.
D000203:Activities of Daily Living; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004145:Diosmin / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use; D006569:Hesperidin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D011788:Quality of Life; D014648:Varicose Veins / Q000150:complications / Q000188:drug therapy; D014689:Venous Insufficiency / Q000150:complications / Q000188:drug therapy
D004338:Drug Combinations; D005419:Flavonoids; C080675:S 5682; D004145:Diosmin; D006569:Hesperidin